As of 1:00pm ET
| -0.40 / -3.60%|
The 4 analysts offering 12-month price forecasts for Tetraphase Pharmaceuticals Inc have a median target of 15.50, with a high estimate of 21.00 and a low estimate of 10.00. The median estimate represents a +44.86% increase from the last price of 10.70.
The current consensus among 8 polled investment analysts is to Hold stock in Tetraphase Pharmaceuticals Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.